The Italian manufacturer of mineral supplements and medical devices for muscles and joints, PharmaNutra, has signed three new distribution contracts for its products abroad, specifically in Morocco, Bahrain, and Peru. These three new markets bring the company's total presence to 88 countries worldwide. In Morocco, the protocol signed last September outlines the distribution of three flagship products starting in 2026. These formulas are designed to address iron deficiencies and help restore vital functions in cases of persistent fatigue. «With the signing of these three new contracts, PharmaNutra reaches the significant milestone of being present in 88 foreign countries», commented Carlo Volpi, CEO of PharmaNutra. «These are impressive figures, achieved in just over ten years of the group's international expansion, making them all the more meaningful», he added with satisfaction. Founded in 2003 by brothers Andrea and Roberto Lacorte, the company emphasizes the scientific value of its products, which are the result of extensive research and development. For the CEO, this is a key strength, allowing the company to «view the present with great satisfaction and the future with the same optimism».
